• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在德系犹太人中,核苷酸1226处戈谢病突变的高频率。

High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.

作者信息

Zimran A, Gelbart T, Westwood B, Grabowski G A, Beutler E

机构信息

Department of Medicine, Shaare Zedek Medical Center, Jerusalem.

出版信息

Am J Hum Genet. 1991 Oct;49(4):855-9.

PMID:1897529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1683177/
Abstract

Reliable estimates of the frequency of Gaucher disease-producing mutations are not available. The high frequency of Gaucher disease in the Ashkenazi Jewish population is due to the occurrence of a mutation at nucleotide (nt) 1226. We have screened 593 DNA samples from normal Ashkenazi Jews, as well as 62 DNA samples from all our Ashkenazi Jewish patients with Gaucher disease, for the presence of the 1226 mutation. In the 593 presumed normal Ashkenazi Jewish individuals the 1226 mutation was identified in the heterozygous state in 37 and in the homozygous state in two, giving a gene frequency of .035 for the mutation. This 1226 mutation represented 73% of the 124 Gaucher disease alleles in Jewish Gaucher disease patients. Accordingly we estimate that the gene frequency for Gaucher disease among the Ashkenazi Jewish population is .047, which is equivalent to a carrier frequency of 8.9% and a birth incidence of 1:450.

摘要

目前尚无对产生戈谢病的突变频率的可靠估计。在德系犹太人中戈谢病的高发病率是由于在核苷酸(nt)1226处发生了一种突变。我们筛查了593份来自正常德系犹太人的DNA样本,以及62份来自我们所有患戈谢病的德系犹太患者的DNA样本,以检测1226突变的存在情况。在593名推测为正常的德系犹太个体中,有37人检测到处于杂合状态的1226突变,2人检测到处于纯合状态的该突变,该突变的基因频率为0.035。在犹太戈谢病患者的124个戈谢病等位基因中,这种1226突变占73%。因此,我们估计德系犹太人群中戈谢病的基因频率为0.047,这相当于携带者频率为8.9%,出生发病率为1:450。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93d/1683177/d1aad7cdabbf/ajhg00081-0164-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93d/1683177/d1aad7cdabbf/ajhg00081-0164-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93d/1683177/d1aad7cdabbf/ajhg00081-0164-a.jpg

相似文献

1
High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.在德系犹太人中,核苷酸1226处戈谢病突变的高频率。
Am J Hum Genet. 1991 Oct;49(4):855-9.
2
Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.对阿什肯纳兹犹太人群进行囊性纤维化、戈谢病和泰-萨克斯病的携带者筛查:纽约大学医学中心(位于纽约州纽约市)的前1000例病例
Arch Intern Med. 1998 Apr 13;158(7):777-81. doi: 10.1001/archinte.158.7.777.
3
Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.以色列阿什肯纳兹犹太人群中葡萄糖脑苷脂酶突变的患病率。
Hum Mutat. 1998;12(4):240-4. doi: 10.1002/(SICI)1098-1004(1998)12:4<240::AID-HUMU4>3.0.CO;2-J.
4
Gaucher disease: gene frequencies in the Ashkenazi Jewish population.戈谢病:德系犹太人种群中的基因频率
Am J Hum Genet. 1993 Jan;52(1):85-8.
5
Lower frequency of Gaucher disease carriers among Tay-Sachs disease carriers.在患有泰-萨克斯病的携带者中,戈谢病携带者的比例较低。
Eur J Hum Genet. 1998 Mar-Apr;6(2):185-6. doi: 10.1038/sj.ejhg.5200176.
6
Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.通过突变分析对阿什肯纳兹犹太人中常见疾病进行特定人群筛查。
Hum Mutat. 1996;8(2):116-25. doi: 10.1002/(SICI)1098-1004(1996)8:2<116::AID-HUMU3>3.0.CO;2-9.
7
Type 2 Gaucher disease occurs in Ashkenazi Jews but is surprisingly rare.2型戈谢病发生在德系犹太人中,但令人惊讶的是极为罕见。
Blood Cells Mol Dis. 2009 Nov-Dec;43(3):294-7. doi: 10.1016/j.bcmd.2009.08.004. Epub 2009 Sep 5.
8
Ashkenazi Jewish genetic disorders.阿什肯纳兹犹太人的遗传疾病。
Fam Cancer. 2004;3(3-4):201-6. doi: 10.1007/s10689-004-9545-z.
9
The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.在巴西犹太人群体中,导致泰-萨克斯病的突变频率证明了开展携带者筛查项目的合理性。
Sao Paulo Med J. 2001 Jul 5;119(4):146-9. doi: 10.1590/s1516-31802001000400007.
10
An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H.阿什肯纳兹犹太人群中戈谢病突变分布的最新情况:R496H突变的患病率及起源国家。
Isr Med Assoc J. 2014 Nov;16(11):683-5.

引用本文的文献

1
Long-Term Evaluation of Biomarkers in the Czech Cohort of Gaucher Patients.捷克戈谢病患者队列的生物标志物长期评估。
Int J Mol Sci. 2023 Sep 22;24(19):14440. doi: 10.3390/ijms241914440.
2
Gaucher disease protects against tuberculosis.戈谢病可预防结核病。
Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2217673120. doi: 10.1073/pnas.2217673120. Epub 2023 Feb 6.
3
Prevalence of lysosomal storage disorders in Australia from 2009 to 2020.2009年至2020年澳大利亚溶酶体贮积症的患病率。

本文引用的文献

1
Gaucher's disease without splenomegaly. Oldest patient on record, with review.无脾肿大的戈谢病。有记录以来最年长的患者,并附文献综述。
N Y State J Med. 1962 Jul 15;62:2346-54.
2
Gaucher's disease: unexpected diagnosis in three patients over seventy years old.
Nouv Rev Fr Hematol (1978). 1984;26(3):201-3.
3
The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.通过检测外周血白细胞中β-葡萄糖苷酶活性缺乏来诊断成人型戈谢病及其携带者状态。
Lancet Reg Health West Pac. 2021 Dec 12;19:100344. doi: 10.1016/j.lanwpc.2021.100344. eCollection 2022 Feb.
4
Screening for Gaucher Disease Using Dried Blood Spot Tests: A Japanese Multicenter, Cross-sectional Survey.应用干血斑检测法筛查戈谢病:一项日本多中心、横断面调查。
Intern Med. 2021;60(5):699-707. doi: 10.2169/internalmedicine.5064-20. Epub 2021 Mar 1.
5
Diffuse large B-cell non-Hodgkin's lymphoma in Gaucher disease.戈谢病中的弥漫性大B细胞非霍奇金淋巴瘤
Mol Genet Metab Rep. 2020 Oct 21;25:100663. doi: 10.1016/j.ymgmr.2020.100663. eCollection 2020 Dec.
6
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.全球杜氏肌营养不良症的流行病学:一项更新的系统评价和荟萃分析。
Orphanet J Rare Dis. 2020 Jun 5;15(1):141. doi: 10.1186/s13023-020-01430-8.
7
Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations.药理学伴侣:一种治疗由不稳定错义突变引起的疾病的方法。
Int J Mol Sci. 2020 Jan 13;21(2):489. doi: 10.3390/ijms21020489.
8
Three cases of multi-generational Gaucher disease and colon cancer from an Ashkenazi Jewish family: A lesson for cascade screening.来自一个阿什肯纳兹犹太家庭的三例多代戈谢病和结肠癌病例:串联筛查的一个教训
Mol Genet Metab Rep. 2019 Jan 4;18:19-21. doi: 10.1016/j.ymgmr.2019.01.001. eCollection 2019 Mar.
9
Gaucher Disease: New Expanded Classification Emphasizing Neurological Features.戈谢病:强调神经学特征的新扩展分类
Iran J Child Neurol. 2019 Winter;13(1):7-24.
10
Pharmacotherapy of Gaucher Disease: Current and Future Options.戈谢病的药物治疗:现状与未来选择
P T. 2018 May;43(5):274-309.
J Lab Clin Med. 1970 Nov;76(5):747-55.
4
Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA.人葡萄糖脑苷脂酶cDNA的分子克隆及核苷酸序列
Proc Natl Acad Sci U S A. 1985 Nov;82(21):7289-93. doi: 10.1073/pnas.82.21.7289.
5
An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A.一种通过分析扩增的DNA序列进行遗传性疾病产前诊断的改进方法。应用于甲型血友病。
N Engl J Med. 1987 Oct 15;317(16):985-90. doi: 10.1056/NEJM198710153171603.
6
Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.1型戈谢病的遗传异质性:德系犹太人和非德系犹太人个体中的多种基因型
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2349-52. doi: 10.1073/pnas.85.7.2349.
7
Prediction of severity of Gaucher's disease by identification of mutations at DNA level.
Lancet. 1989 Aug 12;2(8659):349-52. doi: 10.1016/s0140-6736(89)90536-9.
8
Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.设计用于检测ras癌基因点突变的诊断性限制性片段长度多态性。
Oncogene Res. 1989;4(3):235-41.
9
Gaucher disease: molecular heterogeneity and phenotype-genotype correlations.戈谢病:分子异质性与表型-基因型相关性
Am J Hum Genet. 1989 Aug;45(2):212-25.
10
Detection of the 1226 (Jewish) mutation for Gaucher's disease by color PCR. A means for studying the gene frequency of the disorder.
Am J Clin Pathol. 1990 Jun;93(6):788-91. doi: 10.1093/ajcp/93.6.788.